Manufacturing

Mustang Bio announced that it has entered into a lease agreement with the UMass Medicine Science Park in Worcester, Massachusetts, for a manufacturing facility to support the clinical…
Read More...

Recipharm has equipped its sixth facility with serialisation capabilities ahead of the US and European regulation enforcement deadlines. The facility in Lisbon is the latest of…
Read More...

Servier CDMO announces that the company has invested $7.5 million USD in intensified technology included continuous chromatography with simulated moving beds (SMB) and super critical…
Read More...

Merck announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance viral and gene therapy products has completed both a U.S. Food & Drug…
Read More...

Eli Lilly and Company announced plans to invest $72 million in an insulin manufacturing project at one of its Indianapolis facilities. The investment will be used to replace an existing…
Read More...

CordenPharma has entered into definite agreements to acquire the former Hospira Boulder (Colorado) high containment API site from Pfizer, Inc. The closing of the transaction is…
Read More...

Sanofi is investing €170 million to expand a vaccine manufacturing site in Val de Reuil, France. The expansion further strengthens Sanofi's position as one of the world's leading…
Read More...

Piramal Pharma Solutions (PPS) announced investments of $55 million across its sites in North America & Asia, to expand its API manufacturing capabilities and capacities. A part…
Read More...

Merck announced its strategic decision to discontinue the development of the investigational combination regimens MK-3682B (grazoprevir/ruzasvir/ uprifosbuvir) and MK-3682C…
Read More...

Avara Pharmaceutical Services has signed and closed on an agreement with AstraZeneca to acquire the Reims, France manufacturing and distribution facility. "This key acquisition is…
Read More...

Pilgrim Quality Solutions announced the validated release of SmartSolve Out Of Specification (OOS) Management. Pilgrim’s out-of-specification software drives consistent OOS…
Read More...

Recipharm AB announces today that it has entered into collaboration with Roche and signed a long-term manufacturing agreement whereby Recipharm will manufacture a range of solid dose…
Read More...

MilliporeSigma announced the opening of its first BioReliance End-to-End Biodevelopment Center in the Asia Pacific (APAC) region. Located in Shanghai, China, the center will provide a…
Read More...

Building on decades of innovation in vaccine development and immunization, PATH announced today it has received a $120 million grant from the Bill & Melinda Gates Foundation to…
Read More...

Alcami Corporation announced the unveiling of its new analytical testing facility, located at 4260 Forest Park Avenue, in the Cortex Innovation Community, a 200-acre innovation hub and…
Read More...

Bioverativ and Bicycle Therapeutics announced a research collaboration focused on the discovery, development and commercialization of innovative therapies for hemophilia and sickle cell…
Read More...

Cambrex Corporation announced that it is expanding its High Point, NC facility with the addition of a new $3.2 million, 11,000 sq. ft. analytical laboratory. The investment comes in…
Read More...

Medivir AB and Ascletis announce that Ascletis has licensed the exclusive rights to develop, manufacture and commercialize Medivir's nucleotide polymerase inhibitor for hepatitis C,…
Read More...

Valeant Pharmaceuticals International announced that the U.S. Food and Drug Administration (FDA) confirmed it intends to issue a Voluntary Action Indicated (VAI) inspection…
Read More...

Avara Pharmaceutical Services has signed an agreement with Pfizer Inc. to acquire the Liscate, Italy sterile manufacturing facility. "This acquisition is an important component of our…
Read More...